GB0401862D0 - Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders - Google Patents

Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders

Info

Publication number
GB0401862D0
GB0401862D0 GB0401862A GB0401862A GB0401862D0 GB 0401862 D0 GB0401862 D0 GB 0401862D0 GB 0401862 A GB0401862 A GB 0401862A GB 0401862 A GB0401862 A GB 0401862A GB 0401862 D0 GB0401862 D0 GB 0401862D0
Authority
GB
United Kingdom
Prior art keywords
derivatives
pyrazolo
combinations
treatment
depressive disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0401862A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0401862A priority Critical patent/GB0401862D0/en
Publication of GB0401862D0 publication Critical patent/GB0401862D0/en
Priority to EP04797973A priority patent/EP1687000A2/en
Priority to PCT/EP2004/013070 priority patent/WO2005048999A2/en
Priority to US10/595,800 priority patent/US20070270428A1/en
Priority to JP2006540317A priority patent/JP2007511569A/en
Ceased legal-status Critical Current

Links

GB0401862A 2003-11-19 2004-01-28 Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders Ceased GB0401862D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0401862A GB0401862D0 (en) 2004-01-28 2004-01-28 Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
EP04797973A EP1687000A2 (en) 2003-11-19 2004-11-17 Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders
PCT/EP2004/013070 WO2005048999A2 (en) 2003-11-19 2004-11-17 Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders
US10/595,800 US20070270428A1 (en) 2003-11-19 2004-11-17 Use of Cyclooxygenase-2 Inhibitors for the Treatment of Depressive Disorders
JP2006540317A JP2007511569A (en) 2003-11-19 2004-11-17 Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0401862A GB0401862D0 (en) 2004-01-28 2004-01-28 Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders

Publications (1)

Publication Number Publication Date
GB0401862D0 true GB0401862D0 (en) 2004-03-03

Family

ID=31971607

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0401862A Ceased GB0401862D0 (en) 2003-11-19 2004-01-28 Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders

Country Status (1)

Country Link
GB (1) GB0401862D0 (en)

Similar Documents

Publication Publication Date Title
IL176737A0 (en) Pyrazolo[1,5-a] pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
ZA200802998B (en) Use of pyrazolo [1,5-a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases
IL189980A0 (en) Novel imidazo [4,5-b]pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
HK1134486A1 (en) 4, 5-dihydro- [1, 2, 4] triazolo [4,3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders plk1 45--[124][43- f]
EP1796467A4 (en) Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
HK1226399A1 (en) Pyridazine derivatives and their use as therapeutic agents
ZA200704476B (en) Pyrazolo[1,5-a]pyrimidines useful as inhibitors of protein kinases
IL230241A (en) Retinal derivatives and methods for the use thereof for the treatment of visual disorders
IL183110A0 (en) Certain imidazo[1,2-a]pyrazin-8-ylamines, method of making, and method of use thereof
IL180757A0 (en) Imidazo[4,5-d] pyrimidines, their uses and methods of preparation
WO2007058850A3 (en) Inhibitors of akt activity
PT2217578E (en) [1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their use
WO2007084557A3 (en) Azaindoles useful as inhibitors of janus kinases
PT2942082T (en) A2a receptor antogonists for use in the treatment of movement disorders
EP1664051A4 (en) Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
MX2009002995A (en) Pyrazolo [1, 5-a] pyrimidine derivatives and their therapeutic use.
HK1075844A1 (en) Formulation and methods for the treatment of thrombocythemia
WO2006113837A3 (en) Inhibitors of akt activity
ZA200705035B (en) Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity
WO2007058852A3 (en) Inhibitors of akt activity
ZA200809016B (en) 4, 5-Dihydro-[1,2,4] Triazolo [4,3-F] PteridinesS as protein kinase PLK1 inhibitors for the treatment of proliferative disorders
GB0401862D0 (en) Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
WO2007058879A3 (en) Inhibitors of akt activity
IL181900A0 (en) 7-aminomethyl-1,2,4-triazolo[1,5-a] pyrimidine compounds and their use for controlling pathogenic fungi
GB0312101D0 (en) Use of pyrazolo[1,5-B]pyridazine derivatives for the treatment of psychiatric disorders

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)